Skip to main content
Fig. 1 | BMC Neuroscience

Fig. 1

From: Increased expression of pathological markers in Parkinson’s disease dementia post-mortem brains compared to dementia with Lewy bodies

Fig. 1

Increased Aβ42 in PDD and decreased p-TauS199/202 levels in DLB. Multivariate analysis of post-mortem samples from the TC and CP regions of controls and individuals with PDD and DLB. a Protein levels of Aβ42 in the TC by ELISA assay; 100 µg of each protein sample was used per ELISA reaction. N  = 5. b p-APPT668 and APP protein levels were measured in the TC samples by western blot. Twenty micrograms of protein were used per well for SDS-PAGE. Protein values are normalized to β-actin levels and control samples. Blots were cropped from different gels. Representative western blot images were shown. All blot images with significant changes were included in the Additional file 1: Fig. S1. c Statistical results of relative p-APPT668 protein levels normalized to APP levels in the TC. d p-TauS199/202 protein levels were measured in CP by western blot. Blots were cropped from different gels. Representative western blot images were shown. Protein values are normalized to β-actin levels and control samples. e Statistical results of relative p-TauS199/202 levels in the CP samples. Data are presented as the mean  ±  SEM. Kruskal–Wallis test was used to measure the differences between Control, PDD, and DLB samples. *p  < 0.05, **p  < 0.01, ***p  < 0.001. Sample numbers, Control  = 9, PDD  = 10, and DLB  = 9

Back to article page